Article Details

Aprea Therapeutics, Inc. (NASDAQ:APRE) Receives $3.25 Average PT from Analysts

Retrieved on: 2022-07-10 17:15:55

Tags for this article:

Click the tags to see associated articles and topics

Aprea Therapeutics, Inc. (NASDAQ:APRE) Receives $3.25 Average PT from Analysts. View article details on hiswai:

Excerpt

Renaissance Technologies LLC now owns 297,900 shares of the company's stock valued at $554,000 after purchasing an additional 15,977 shares during the ...

Article found on: www.defenseworld.net

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up